findmyKOL
Clinical trialNCT07390552RecruitingPhase 2Interventional

A Study of PLH-2301 in Subjects With Sarcopenia

SponsorPluto Inc.Enrollment168Sarcopenia in Elderly
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

This is a Phase 2, randomized, double-blind, placebo-controlled, parallel-group study to evaluate the efficacy and safety of PLH-2301 in subjects with sarcopenia. Eligible subjects aged 65 years and older will be randomized to receive placebo or one of three dose levels of PLH-2301 once daily for 12 weeks. The primary objective is to assess the effect of PLH-2301 on physical function compared with placebo.
clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

5 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

South Korea
  • Seoul National University Bundang Hospital

    Seongnam-si, Gyeonggi-do, South Korea

    Recruiting
  • the Catholic University of Korea, St. Vincent'S Hospital

    Suwon, Gyeonggi-do, South Korea

    Recruiting
  • Korea University Anam Hospital

    Seoul, Seoul, South Korea

    Recruiting
  • Korea University Guro Hospital

    Seoul, Seoul, South Korea

    Recruiting
  • Seoul St. Mary'S Hospital

    Seoul, Seoul, South Korea

    Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

PLH-2301Placebo
Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
8 May 2026
Primary completion
30 Jun 2027
Completion
30 Jun 2027
Last update posted
12 May 2026
Registered enrollment
168
Registry id
NCT07390552
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.